Pyxis Oncology (PYXS) Institutional Ownership

$4.64
+0.11 (+2.43%)
(As of 10:46 AM ET)

Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)

Current
Institutional Ownership
Percentage
39.09%
Number of
Institutional Buyers
(last 12 months)
15
Total
Institutional Inflows
(last 12 months)
$4.37M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$4.26M
Get PYXS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PYXS Institutional Buying and Selling by Quarter

Pyxis Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/20/2024Cable Car Capital LLC61,606$111K0.1%N/A0.139%
2/14/2024Vestal Point Capital LP440,000$792K0.1%N/A0.993%
2/12/2024Decheng Capital LLC326,810$588K0.2%N/A0.737%
1/31/2024abrdn plc708,303$1.28M0.0%N/A1.598%
11/29/2023Decheng Capital Management III Cayman LLC326,810$650K0.2%N/A0.737%
11/15/2023Radcliffe Capital Management L.P.53,288$106K0.0%N/A0.120%
11/14/2023Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050%
11/13/2023Acadian Asset Management LLC13,233$26K0.0%N/A0.030%
10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033%
8/14/2023Prelude Capital Management LLC10,352$27K0.0%N/A0.027%
8/11/2023Harvest Investment Services LLC116,428$298K0.2%+27.9%0.304%
8/11/2023ExodusPoint Capital Management LP259,561$664K0.0%+270.8%0.679%
8/10/2023Cetera Investment Advisers18,260$47K0.0%N/A0.048%
7/10/2023SG Americas Securities LLC20,497$52K0.0%N/A0.054%
5/16/2023Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435%
5/4/2023Barclays PLC118,223$474K0.0%-87.5%0.320%
4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049%
2/15/2023Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888%
2/9/2023Citigroup Inc.357,537$479K0.0%+14.5%1.019%
1/12/2023Marquette Asset Management LLC58,862$79K0.0%N/A0.168%
11/15/2022Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022%
11/14/2022RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179%
8/15/2022Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966%
8/15/2022Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662%
5/16/2022Ghost Tree Capital LLC75,000$303K0.1%-74.6%0.228%
5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157%
2/16/2022Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900%
2/15/2022Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548%
2/15/2022Davidson Kempner Capital Management LP10,000$109K0.0%N/A0.031%
2/14/2022Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644%
2/14/2022Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952%
2/14/2022Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333%
2/14/2022Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934%
2/14/2022Sandia Investment Management LP10,000$110K0.0%N/A0.031%
2/14/2022Ghisallo Capital Management LLC30,000$329K0.0%N/A0.092%
2/8/2022Northern Trust Corp89,235$979K0.0%N/A0.272%
2/2/2022New York State Common Retirement Fund6,277$69K0.0%N/A0.019%
(Data available from 1/1/2016 forward)

PYXS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PYXS shares?

During the previous two years, 25 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were Laurion Capital Management LP ($7.55M), Tang Capital Management LLC ($4.65M), Tekla Capital Management LLC ($2.63M), Hhlr Advisors LTD. ($2.13M), Acuta Capital Partners LLC ($1.54M), RA Capital Management L.P. ($1.51M), and abrdn plc ($1.28M).Learn more on PYXS's institutional investors.

What percentage of Pyxis Oncology stock is owned by institutional investors?

39.09% of Pyxis Oncology stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings.

Which institutional investors have been buying Pyxis Oncology stock?

Of the 21 institutional investors that purchased Pyxis Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($2.09M), Laurion Capital Management LP ($1.95M), abrdn plc ($708.30K), Tekla Capital Management LLC ($573.30K), Acuta Capital Partners LLC ($445.15K), Vestal Point Capital LP ($440K), and Decheng Capital LLC ($326.81K).

How much institutional buying is happening at Pyxis Oncology?

Institutional investors have bought a total of 7,412,295 shares in the last 24 months. This purchase volume represents approximately $15.35M in transactions.

Which Pyxis Oncology major shareholders have been selling company stock?

The following institutional investors have sold Pyxis Oncology stock in the last 24 months: Barclays PLC ($829.83K), Hhlr Advisors LTD. ($233.71K), Ghost Tree Capital LLC ($220K), and RA Capital Management L.P. ($188.74K).

How much institutional selling is happening at Pyxis Oncology?

Institutional investors have sold a total of 1,472,282 shares in the last 24 months. This volume of shares sold represents approximately $5.53M in transactions.


This page (NASDAQ:PYXS) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners